Skip to main content
NKMAX Co., Ltd. logo

NKMAX Co., Ltd. — Investor Relations & Filings

Ticker · 182400 ISIN · KR7182400002 KO Manufacturing
Open in API
Filings indexed 501 across all filing types
Latest filing 2021-08-27 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 182400

About NKMAX Co., Ltd.

https://nkmax.com/

NKMAX Co., Ltd. is a biotechnology company focused on developing immune-based solutions centered on Natural Killer (NK) cells. The company's primary focus is the development of adoptive cell therapies to treat incurable diseases, including cancer, autoimmune disorders, and neurodegenerative conditions. Its portfolio includes anti-cancer immunotherapy treatments and other biological products. In addition to therapeutics, NKMAX develops and markets a precision diagnostic test that measures NK cell activity. The company also manufactures and supplies specialized reagents, such as high-quality recombinant proteins and antibodies, for biotechnology research, as well as a line of health functional foods designed to support the immune system.

Recent filings

Filing Released Lang Actions
전환가액의조정
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from NKMAX regarding the adjustment of the conversion price of convertible bonds (CB). It details the change in conversion price due to a decline in market price, the calculation method, and the resulting change in the number of convertible shares. This type of disclosure is a standard capital structure update related to financing instruments, which falls under the 'Capital/Financing Update' category.
2021-08-27 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document details the shareholding status, changes in shareholding, and contractual agreements (such as collateral/pledge agreements) of major shareholders. It is a formal disclosure of significant ownership levels and changes, which corresponds to the 'Major Shareholding Notification' category.
2021-08-18 Korean
반기보고서 (2021.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for the company NKMAX, covering the period from January 1, 2021, to June 30, 2021. It contains detailed corporate information, capital structure, and management details, which are characteristic of an interim financial report. According to the provided definitions, a comprehensive financial report for a period shorter than a full fiscal year is classified as an Interim / Quarterly Report (IR). H1 2021
2021-08-17 Korean
[기재정정]사업보고서 (2020.12)
Regulatory Filings Classification · 95% confidence The document is a 'Correction Report' (정정신고) for a previously filed 'Business Report' (사업보고서), which is the Korean equivalent of a 10-K. It details specific amendments to sections such as dividend policy, articles of incorporation, research and development activities, and capital usage. Since it is a formal regulatory filing amending a comprehensive annual report, it falls under the category of Regulatory Filings (RNS) as it is a compliance-related update rather than the primary annual report itself. FY 2020
2021-07-12 Korean
[기재정정]분기보고서 (2021.03)
Interim / Quarterly Report Classification · 95% confidence The document is a '정정신고(보고)' (Correction Report) for a '분기보고서' (Quarterly Report). It details specific amendments made to the previously filed quarterly report, including updates to dividend policies, articles of incorporation, research and development activities, and investment details. Since this document is a formal amendment to an existing quarterly report and contains substantive financial and operational data updates, it is classified as an Interim/Quarterly Report (IR) filing. Q1 2021
2021-07-12 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report of Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (FSS) and the Korea Exchange. This document details the change in share ownership (specifically a decrease due to the resignation of an executive) by a director of NKMAX Co., Ltd. In the provided classification schema, reports detailing personal share transactions by company directors and executives are classified as 'Director's Dealing' (DIRS).
2021-07-12 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.